Navigation Links
Cure Insight for DMD

According to the researcher Dr. Jacques P. Tremblay who is in the Human Genetics Department at Quebec City's Centre Hospitalier Universitaire de Québec (CHUQ) // and professor with Université Laval's Faculty of Medicine muscle cell transplant is one of the important alternatives to cure Duchenne muscular dystrophy. He and his team of researchers conducted the muscle cell transplant in young patients in 2004. The results were that eight out of the nine patients showed improvement. Duchenne muscular dystrophy is a progressive weakening and degeneration of the muscles, caused by a mutation in a gene coding for a protein called dystrophin.

This protein is absent in the muscles of people affected with the disorder. With the healthy muscle cells grafted by the team of researchers, a considerable proportion of patients' muscle fibers are now able to synthesize the missing protein. Analyses showed that between 4% and 26% of muscle cells in the cubic centimeter of treated muscle eventually produce the protein produced by the fusion of the donor cells. The results are published in the latest issue of the Journal of Neuropathology and Experimental Neurology. Dr. Tremblay's team is the first in the world to achieve this level of dystrophin expression in so many patients, and in such a high percentage of fibers.

Duchenne muscular dystrophy is a hereditary disease affecting one boy in 3,500. The first signs appear in childhood, between the ages of two and five. Its victims are confined to a wheelchair by their early teens. The disease progressively weakens all muscles, notably respiratory muscles, compromising life expectancy. Most sufferers die between the ages of 20 and 30. Today, there is no treatment--only rehabilitation, surgical procedures and prednisone to enhance patients' quality of life. New clinical trial: seeking ten patients Based on these results, professor Tremblay has received authorization to conduct a second round of clinical trials.
These new trials are supported financially by SOVAR, CellGene Inc., and Association Fran?aise contre les Myopathies. In this second trial, some 300 million donor cells will be transplanted into a complete muscle in the recipient's forearm. Patients' strength will be measured before their grafts, then three and six months after. This experiment will enable researchers to determine whether the transplant significantly increases the strength of the grafted muscle. Dr. Tremblay's team is seeking ten patients over the age of 18 who suffer from Duchenne or Becker muscular dystrophy. Patients are asked to talk to their neurologists, who can help them contact the researchers. Dr. Tremblay received the 2005 Sirius research award for his work on Duchenne muscular dystrophy. More recently, the Royal College of Physicians and Surgeons of Canada and the Canadian Society for Clinical Investigation together awarded him the Henry-Friesen Award honoring a distinguished scientist whose biomedical research is recognizable on the international stage as novel and original and of the highest caliber. The multidisciplinary CHUQ team headed by Dr. Jacques P. Tremblay includes Dr. Daniel Skuk, Dr. Michel Sylvain, Dr. Jack Puymirat, Dr. Jean-Pierre Bouchard, Dr. Louise Deschènes, Dr. Hélène Senay, Dr. Jean-Guy Lachance, Dr. Raynald Roy, and Dr. Pierre Dalens.

'"/>




Related medicine news :

1. fMRI Offers Insight Into An Infants Brain
2. New Insight To The Role Of Peptide Signals
3. New Insight Gained For Allergic Reactions
4. Insight for Hot Flashes In Postmenopausal Women
5. New Insight In Periodontal Disease In Postmenopausal Women
6. Researchers Bring New Insight To Asthma And SABA Fills
7. Study Unveils New Insight To The Madness Of King George III
8. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
9. Reindeer Provide Valuable Insights Into Sleep Disorders
10. Insight Into The Risky Health Decisions On Bird Flu
11. Insights Into Lead Pollution
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management Association (RBMA) ... annual awards, now in their 12th year, are among the most prestigious in radiology ... 2016, the awards were retooled to recognize achievements in both large budget (over $5,000) ...
(Date:3/24/2017)... Arizona (PRWEB) , ... March 24, 2017 , ... ... Healing Center, Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, ... Luis Delgado, June 9--24, 2017. This sacred and spiritual journey during the ...
(Date:3/24/2017)... ... ... The law firm of Enea, Scanlan & Sirignano, LLP, with ... C. Enea has joined the firm as an associate attorney. Ms. Enea, who previously ... law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha A. Lyons, ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding Christ Through Social ... devotional journal chronicling the writer’s path toward true communion with God. “Finding Christ ... #TruthwithGrace” is the creation of published author Lea Michelle Johnson, a follower of ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health Organization ... could be four million Zika-related cases in the Americas within the next year. Lyme ... cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... YORK , March 24, 2017 ... ... a leading publisher of cannabis market research, the legal cannabis ... percent CAGR through 2021, despite conflicting signals from the current ... points out that the two biggest drivers of growth in ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 ... market of deep learning solutions within the healthcare domain. Primarily driven ... a novel solution to generate relevant insights from medical data. ...
(Date:3/24/2017)... -- Today Stock-Callers.com have issued research reports on ... (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. (NYSE: ... These companies are part of the Healthcare sector, which gave ... rd , 2017, with the NYSE Health Care Index declining ... in the S&P 500 were down about 0.4% as a ...
Breaking Medicine Technology: